395 related articles for article (PubMed ID: 23063511)
21. Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro.
Gole B; Durán Alonso MB; Dolenc V; Lah T
Pathol Oncol Res; 2009 Dec; 15(4):711-23. PubMed ID: 19434518
[TBL] [Abstract][Full Text] [Related]
22. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
[TBL] [Abstract][Full Text] [Related]
23. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis.
Wang HX; Sharma C; Knoblich K; Granter SR; Hemler ME
Cell Res; 2015 Mar; 25(3):370-85. PubMed ID: 25656846
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose.
Jung M; Lee J; Seo HY; Lim JS; Kim EK
PLoS One; 2015; 10(1):e0116972. PubMed ID: 25625842
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro.
Teti A; De Giorgi A; Spinella MT; Migliaccio S; Canipari R; Onetti Muda A; Faraggiana T
Int J Cancer; 1997 Sep; 72(6):1013-20. PubMed ID: 9378535
[TBL] [Abstract][Full Text] [Related]
27. Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells.
Sokol JP; Schiemann WP
Mol Cancer Res; 2004 Mar; 2(3):183-95. PubMed ID: 15037657
[TBL] [Abstract][Full Text] [Related]
28. Long-term cyclosporin A exposure suppresses cathepsin-B and -L activity in gingival fibroblasts.
Yamaguchi M; Naruishi K; Yamada-Naruishi H; Omori K; Nishimura F; Takashiba S
J Periodontal Res; 2004 Oct; 39(5):320-6. PubMed ID: 15324353
[TBL] [Abstract][Full Text] [Related]
29. Melanoma growth and progression after ultraviolet a irradiation: impact of lysosomal exocytosis and cathepsin proteases.
Eding CB; Domert J; Wäster P; Jerhammar F; Rosdahl I; Öllinger K
Acta Derm Venereol; 2015 Sep; 95(7):792-7. PubMed ID: 25669167
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
Ramont L; Pasco S; Hornebeck W; Maquart FX; Monboisse JC
Exp Cell Res; 2003 Nov; 291(1):1-10. PubMed ID: 14597403
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.
Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M
Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464
[TBL] [Abstract][Full Text] [Related]
32. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
[TBL] [Abstract][Full Text] [Related]
33. Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.
Colella R; Jackson T; Goodwyn E
Biotech Histochem; 2004; 79(3-4):121-7. PubMed ID: 15621884
[TBL] [Abstract][Full Text] [Related]
34. Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts.
Yamane K; Ihn H; Asano Y; Jinnin M; Tamaki K
J Immunol; 2003 Oct; 171(7):3855-62. PubMed ID: 14500687
[TBL] [Abstract][Full Text] [Related]
35. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
36. Role of the cystathionine γ lyase/hydrogen sulfide pathway in human melanoma progression.
Panza E; De Cicco P; Armogida C; Scognamiglio G; Gigantino V; Botti G; Germano D; Napolitano M; Papapetropoulos A; Bucci M; Cirino G; Ianaro A
Pigment Cell Melanoma Res; 2015 Jan; 28(1):61-72. PubMed ID: 25205294
[TBL] [Abstract][Full Text] [Related]
37. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
[TBL] [Abstract][Full Text] [Related]
38. Effects of TGF-β signaling in clear cell renal cell carcinoma cells.
Boström AK; Lindgren D; Johansson ME; Axelson H
Biochem Biophys Res Commun; 2013 May; 435(1):126-33. PubMed ID: 23618868
[TBL] [Abstract][Full Text] [Related]
39. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells.
Reddy KB; Krueger JS; Kondapaka SB; Diglio CA
Int J Cancer; 1999 Jul; 82(2):268-73. PubMed ID: 10389762
[TBL] [Abstract][Full Text] [Related]
40. In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.
Schmid P; Itin P; Rufli T
Carcinogenesis; 1995 Jul; 16(7):1499-503. PubMed ID: 7614683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]